In the course of our research aimed at the discovery of new compounds acting as aldose reductase inhibitors, we tested a series of some (E)- and (Z)-ω-[[(aryldiazinylmethylene)amino]oxy]alkanoic acids, which were found to have moderate in vitro inhibitory activity. On this basis we have now prepared several new derivatives modified both at the length of the chain and at its terminal carboxylic group, together with compounds carrying various substituents at the phenyl ring. This paper describes their synthesis and biological properties.
A series of diarylsubstituted oximes as potential substrates for new aldose reductase inhibitors / D., Rakowitz; G., Heinisch; P., Lukavsky; S., Kiendler; C., Trenkwalder; D., Barlocco; Rastelli, Giulio; Costantino, Luca. - In: JOURNAL OF HETEROCYCLIC CHEMISTRY. - ISSN 0022-152X. - STAMPA. - 37:5(2000), pp. 1089-1096. [10.1002/jhet.5570370511]
A series of diarylsubstituted oximes as potential substrates for new aldose reductase inhibitors
RASTELLI, Giulio;COSTANTINO, Luca
2000
Abstract
In the course of our research aimed at the discovery of new compounds acting as aldose reductase inhibitors, we tested a series of some (E)- and (Z)-ω-[[(aryldiazinylmethylene)amino]oxy]alkanoic acids, which were found to have moderate in vitro inhibitory activity. On this basis we have now prepared several new derivatives modified both at the length of the chain and at its terminal carboxylic group, together with compounds carrying various substituents at the phenyl ring. This paper describes their synthesis and biological properties.File | Dimensione | Formato | |
---|---|---|---|
A series of diarylsubstitutedALR2-JHetChem2000.pdf
Accesso riservato
Tipologia:
Versione pubblicata dall'editore
Dimensione
490.84 kB
Formato
Adobe PDF
|
490.84 kB | Adobe PDF | Visualizza/Apri Richiedi una copia |
Pubblicazioni consigliate
I metadati presenti in IRIS UNIMORE sono rilasciati con licenza Creative Commons CC0 1.0 Universal, mentre i file delle pubblicazioni sono rilasciati con licenza Attribuzione 4.0 Internazionale (CC BY 4.0), salvo diversa indicazione.
In caso di violazione di copyright, contattare Supporto Iris